S F Hall1, J C Irish2, R W Gregg3, P A Groome4, S Rohland4. 1. Department of Otolaryngology, Queen's University, Kingston, ON. ; Division of Cancer Care and Epidemiology, Queen's University, Kingston, ON. 2. Department of Otolaryngology, Queen's University, Kingston, ON. ; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON. 3. Department of Oncology, Queen's University, Kingston, ON. 4. Division of Cancer Care and Epidemiology, Queen's University, Kingston, ON.
Abstract
BACKGROUND: Clinical practice guidelines (cpgs) are systematically developed statements designed to assist practitioners and patients in making decisions about appropriate heath care interventions. Clinical practice guidelines are expensive and time-consuming to create. A cpg on concurrent chemotherapy with radiation therapy (ccrt) was developed in Ontario at a time when treatment approaches for head-and-neck cancer were changing significantly. METHODS: An assessment of treatments and outcomes based on electronic and chart data obtained from a population-based study of 571 patients with oropharynx cancer treated in Ontario (2003-2004) was combined with a review of relevant knowledge transfer (publications and presentations at major meetings) to understand variation in adherence to a cpg. RESULTS: In 9 Ontario cancer treatment centres, ccrt was used for 55% of all patients with oropharyngeal cancer; however, at the centres individually, that proportion ranged from 82% to 39%. Furthermore, there was no agreement on the chemotherapy regimen: 2-4 years later (a period during which newer regimens were emerging), only 4 of 9 centres were following the guideline for most patients. When outcomes of treated patients were compared for centres with "higher" and "lower" use of ccrt, no difference in survival was observed (p = 0.64). CONCLUSIONS: At a time of treatment evolution, the new guideline was controversial, and there are many reasons for the mixed adherence. An estimation of adherence should be included during both development and review of guidelines.
BACKGROUND: Clinical practice guidelines (cpgs) are systematically developed statements designed to assist practitioners and patients in making decisions about appropriate heath care interventions. Clinical practice guidelines are expensive and time-consuming to create. A cpg on concurrent chemotherapy with radiation therapy (ccrt) was developed in Ontario at a time when treatment approaches for head-and-neck cancer were changing significantly. METHODS: An assessment of treatments and outcomes based on electronic and chart data obtained from a population-based study of 571 patients with oropharynx cancer treated in Ontario (2003-2004) was combined with a review of relevant knowledge transfer (publications and presentations at major meetings) to understand variation in adherence to a cpg. RESULTS: In 9 Ontario cancer treatment centres, ccrt was used for 55% of all patients with oropharyngeal cancer; however, at the centres individually, that proportion ranged from 82% to 39%. Furthermore, there was no agreement on the chemotherapy regimen: 2-4 years later (a period during which newer regimens were emerging), only 4 of 9 centres were following the guideline for most patients. When outcomes of treated patients were compared for centres with "higher" and "lower" use of ccrt, no difference in survival was observed (p = 0.64). CONCLUSIONS: At a time of treatment evolution, the new guideline was controversial, and there are many reasons for the mixed adherence. An estimation of adherence should be included during both development and review of guidelines.
Entities:
Keywords:
Clinical practice guidelines; chemoradiotherapy; head-and-neck cancer; uptake; variation
Authors: N P Nguyen; C C Moltz; C Frank; P Vos; H J Smith; U Karlsson; S Dutta; F A Midyett; J Barloon; S Sallah Journal: Ann Oncol Date: 2004-03 Impact factor: 32.976
Authors: Milena A Gianfrancesco; Gabriela Schmajuk; Sarah Haserodt; Laura Trupin; Zara Izadi; Kashif Jafri; Stephen Shiboski; Marina Sirota; Jinoos Yazdany Journal: Rheumatol Int Date: 2017-07-26 Impact factor: 2.631
Authors: Stephen F Hall; Fei-Fei Liu; Brian O'Sullivan; Willa Shi; Susan Rohland; Rebecca Griffiths; Patti Groome Journal: Br J Cancer Date: 2017-08-22 Impact factor: 7.640
Authors: Lydia F J van Overveld; Robert P Takes; Thomas W Vijn; Jozé C C Braspenning; Jan P de Boer; John J A Brouns; Rolf J Bun; Boukje A C van Dijk; Judith A W F Dortmans; Emilie A C Dronkers; Robert J J van Es; Frank J P Hoebers; Arvid Kropveld; Johannes A Langendijk; Ton P M Langeveld; Sjoukje F Oosting; Hendrik P Verschuur; Jan G A M de Visscher; Stijn van Weert; Matthias A W Merkx; Ludi E Smeele; Rosella P M G Hermens Journal: Health Expect Date: 2017-06-15 Impact factor: 3.377
Authors: Matthew D Hickey; Sarah Lisker; Shauna Brodie; Eric Vittinghoff; Marika D Russell; Urmimala Sarkar Journal: Pilot Feasibility Stud Date: 2020-02-07